Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

452 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Expert consensus on the management of infusion-related reactions (IRRs) in patients with sickle cell disease (SCD) receiving crizanlizumab: a RAND/UCLA modified Delphi panel.
Kanter J, Ataga KI, Bhasin N, Guarino S, Kutlar A, Lanzkron S, Manwani D, McGann P, Stowell SR, Tubman VN, Yermilov I, Campos C, Broder MS. Kanter J, et al. Ann Hematol. 2024 Jun;103(6):1909-1917. doi: 10.1007/s00277-024-05736-6. Epub 2024 Apr 20. Ann Hematol. 2024. PMID: 38642304 Review.
Social determinants of health and treatment center affiliation: analysis from the sickle cell disease implementation consortium registry.
Mendez GG, Nocek JM, Brambilla DJ, Jacobs S, Cole O, Kanter J, Glassberg J, Saving KL, Melvin CL, Gibson RW, Treadwell M, Jackson GL, King AA, Gordeuk VR, Kroner B, Hsu LL; Sickle Cell Disease Implementation Consortium. Mendez GG, et al. Among authors: kanter j. BMC Health Serv Res. 2024 Mar 6;24(1):291. doi: 10.1186/s12913-024-10717-6. BMC Health Serv Res. 2024. PMID: 38448911 Free PMC article.
A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events.
Heeney MM, Hoppe CC, Abboud MR, Inusa B, Kanter J, Ogutu B, Brown PB, Heath LE, Jakubowski JA, Zhou C, Zamoryakhin D, Agbenyega T, Colombatti R, Hassab HM, Nduba VN, Oyieko JN, Robitaille N, Segbefia CI, Rees DC; DOVE Investigators. Heeney MM, et al. Among authors: kanter j. N Engl J Med. 2016 Feb 18;374(7):625-35. doi: 10.1056/NEJMoa1512021. Epub 2015 Dec 8. N Engl J Med. 2016. PMID: 26644172 Free article. Clinical Trial.
Incidence and Risk Factors for New and Recurrent Infarcts in Adults With Sickle Cell Disease.
Jordan LC, King AA, Kanter J, Lebensburger J, Ford AL, Varughese TE, Garrett L, Mullis L, Saint Jean L, Davis S, Dumas J, Kassim AA, Rodeghier M, Hikima MS, Suwaid MA, Saleh MK, DeBaun MR. Jordan LC, et al. Among authors: kanter j. J Am Heart Assoc. 2024 Jun 6:e033278. doi: 10.1161/JAHA.123.033278. Online ahead of print. J Am Heart Assoc. 2024. PMID: 38842282 Free article.
Imbalance of APOB Lipoproteins and Large HDL in Type 1 Diabetes Drives Atherosclerosis.
Kothari V, Ho TWW, Cabodevilla AG, He Y, Kramer F, Shimizu-Albergine M, Kanter JE, Snell-Bergeon J, Fisher EA, Shao B, Heinecke JW, Wobbrock JO, Lee WL, Goldberg IJ, Vaisar T, Bornfeldt KE. Kothari V, et al. Among authors: kanter je. Circ Res. 2024 Jun 3. doi: 10.1161/CIRCRESAHA.123.323100. Online ahead of print. Circ Res. 2024. PMID: 38828596 Free article.
Costs and Impact of Disease in Adults with Sickle Cell Disease: A Pilot Study.
Lanzkron S, Crook N, Wu J, Hussain S, Curtis R, Robertson D, Baker JR, Nugent D, Soni A, Roberts JC, Ullman M Ms, Kanter J, Nichol M. Lanzkron S, et al. Among authors: kanter j. Blood Adv. 2024 May 22:bloodadvances.2023012477. doi: 10.1182/bloodadvances.2023012477. Online ahead of print. Blood Adv. 2024. PMID: 38776399
452 results